Innoviva (INVA) FCF Payout Ratio Growth (5y) (2019 - 2022)
Innoviva (INVA) FCF Payout Ratio Growth (5y) (2019 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 1.00 Bn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 155.02% |
| Jun 30, 2022 | 112.00% |
| Mar 31, 2022 | 94.01% |
| Sep 30, 2021 | 131.85% |
| Jun 30, 2021 | 88.70% |
| Mar 31, 2021 | 20.61% |
| Dec 31, 2020 | 1.73% |
| Jun 30, 2020 | -59.19% |
| Mar 31, 2020 | 15.01% |
| Dec 31, 2019 | -14.91% |
| Sep 30, 2019 | 15.03% |